NE

Nephros IncNASDAQ NEPH Stock Report

Last reporting period 30 Jun, 2024

Updated 15 Nov, 2024

Last price

Market cap $B

0.018

Micro

Exchange

XNAS - Nasdaq

NEPH Stock Analysis

NE

Uncovered

Nephros Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-7/100

Low score

Market cap $B

0.018

Dividend yield

Shares outstanding

10.317 B

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.

View Section: Eyestock Rating